Blepharospasm
Links shared publicly online about this topic
Blepharospasm, Benign Essential: eMedicine Ophthalmology
emedicine.medscape.com — “Overview: The first record of blepharospasm and lower facial spasm was found in the 16th century in a painting titled De Gaper. At that time, and for several ensuing centuries, patients with such spasms were regarded as ...” View full resource at emedicine.medscape.com
Most Recently Shared on August 13, 2010 at 2:30 am By:
FDA Approves IncobotulinumtoxinA for Blepharospasm: http://bit.ly/duyiWQ
Neurology News & Articles - MDLinx - Blepharospasm on #MDlinx
mdlinx.com — “Neurology News & Articles - MDLinx - Blepharospasm on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on August 4, 2010 at 12:45 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Clinical features of patients with blepharospasm: a report of 240 patients: European Journal of ... http://bit.ly/dl4AdK #neurology #mdlinx
Transcranial magnetic brain stimulation modulates blepharospasm --" Neurology
neurology.org — “Transcranial magnetic brain stimulation modulates blepharospasm --" Neurology” View full resource at neurology.org
Most Recently Shared on October 25, 2010 at 12:15 pm By:
Neurology Journal Medical Journal and Neurology
Transcranial magnetic brain stimulation modulates blepharospasm: A randomized controlled study http://bit.ly/bh3Q85 #neurology
Benign essential blepharospasm may not be risk factor for glaucoma
osnsupersite.com — “Patients with benign essential blepharospasm do not have an increased risk of primary open-angle glaucoma, closed-angle glaucoma or other glaucoma,” View full resource at osnsupersite.com
Most Recently Shared on December 14, 2010 at 7:43 pm By:
Benign essential blepharospasm may not be risk factor for #glaucoma: http://ht.ly/3p9A5
Xeomin approved for cervical dystonia and blepharospasm - ONA
oncologynurseadvisor.com — “Merz Pharmaceuticals announced that the FDA has approved Xeomin (incobotulinumtoxinA) for the treatment of adults with cervical dystonia to decrease the severity of abnormal head position and neck pain in both botulinum toxin-nave and previously treated patients and blepharospasm in adults previously treated with onabotulinumtoxinA.” View full resource at oncologynurseadvisor.com
Most Recently Shared on August 2, 2010 at 4:23 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Xeomin approved for cervical dystonia and blepharospasm http://goo.gl/fb/CKYJo
Xeomin available for cervical dystonia and blepharospasm - MPR
empr.com — “Merz Pharmaceuticals has launched Xeomin (incobotulinumtoxinA) for the treatment of adults with cervical dystonia to decrease the severity of abnormal head position and neck pain in both botulinum toxin-nave and previously treated patients and blepharospasm in adults previously treated with onabotulinumtoxinA.” View full resource at empr.com
Most Recently Shared on October 5, 2010 at 2:17 pm By:
MPR News: Xeomin available for cervical dystonia and blepharospasm: Merz Pharmaceuticals has launched Xeomin (inco... http://bit.ly/bDFWpd
Xeomin approved for cervical dystonia and blepharospasm - MPR
empr.com — “Merz Pharmaceuticals announced that the FDA has approved Xeomin (incobotulinumtoxinA) for the treatment of adults with cervical dystonia to decrease the severity of abnormal head position and neck pain in both botulinum toxin-nave and previously treated patients and blepharospasm in adults previously treated with onabotulinumtoxinA.” View full resource at empr.com
Most Recently Shared on August 2, 2010 at 4:17 pm By:
MPR News: Xeomin approved for cervical dystonia and blepharospasm: Merz Pharmaceuticals announced that the FDA has... http://bit.ly/cEumpe
Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm
neurology.org — “Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm” View full resource at neurology.org
Most Recently Shared on August 17, 2011 at 12:26 pm By:
Neurology Journal Medical Journal and Neurology
Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm http://t.co/HsdNHmM #neurology
Blepharospasm: A scary-sounding word for a condition that is (usually) only a temporary nuisance
drryo.com — “Dr. Ryo discusses blepharospasm, or ‘eye twitching.’” View full resource at drryo.com
Most Recently Shared on February 28, 2012 at 1:32 pm By:
Ryo Kubota, MD, PhD Surgeon, Ophthalmologist, Physician, and Doctor
New on http://t.co/wkCtIIJi: Blepharospasm: A scary-sounding word for a condition that is (usually) only a temporar http://t.co/ChtgQxPs
Pharmacy Europe - FDA approves Xeomin for the treatment of cervical dystonia and blepharospasm
pharmacyeurope.net — “Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.” View full resource at pharmacyeurope.net
Most Recently Shared on August 4, 2010 at 6:21 am By:
Drugs and Devices OW OW Health
FDA approves Xeomin for the treatment of cervical dystonia and blepharospasm: Merz Pharmaceuticals has announced t... http://bit.ly/aGazsY
FDA Approves Merz Pharmaceuticals' Xeomin (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
drugs.com — “Xeomin (incobotulinumtoxinA) is used to treat cervical dystonia and blepharospasm. Includes Xeomin side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 2, 2010 at 11:54 pm By:
FDA Approves Xeomin (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm - http://bit.ly/a4RGn1
FDA Approves Merz Pharmaceuticals' Xeomin® (IncobotulinumtoxinA) For The Treatment Of Cervical Dystonia And Blepharospasm
medicalnewstoday.com — “Merz Pharmaceuticals has announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin® (incobotulinumtoxinA), a botulinum toxin type A for the treatment of” View full resource at medicalnewstoday.com
Most Recently Shared on August 3, 2010 at 3:05 pm By:
MNT Neurology News Neurology and Health News
FDA Approves Merz Pharmaceuticals' Xeomin® (IncobotulinumtoxinA) For The Treatment Of Cervical Dystonia And Blepha... http://mnt.to/3GTG
Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm—A randomized trial - Jankovic - 2011 - Movement Disorders - Wiley Online Library
onlinelibrary.wiley.com — “Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm—A randomized trial - Jankovic - 2011 - Movement Disorders - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on April 22, 2011 at 3:00 pm By:
Movement Disorders Health Organization and Neurology
Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm—A randomized trial... http://bit.ly/guBf5t
Eyelid twitch: MedlinePlus Medical Encyclopedia
nlm.nih.gov — “Eyelid twitch: MedlinePlus Medical Encyclopedia” View full resource at nlm.nih.gov
Most Recently Shared on December 28, 2009 at 5:00 pm By:
Ryo Kubota, MD, PhD Surgeon, Ophthalmologist, Physician, and Doctor
Focus on Your Vision Insight: Everything you need to know about blepharospasm: otherwise known as eye twitches: http://ow.ly/FcMP
Neurology Medical News about Spasm
mdlinx.com — “Prospective, Randomized, Double-Blind Study, Comparing Botulinum Toxins Type A Botox and Prosigne for Blepharospasm and Hemifacial Spasm Treatment” View full resource at mdlinx.com
Most Recently Shared on February 3, 2010 at 9:25 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Neuro: Prospective, Randomized, Double-Blind Study, Comparing Botulinum Toxins Type A Botox and Prosigne for Blepharosp http://url4.eu/1IxKn
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Medscape Ophtha
Latest medical news, articles, and features from Medscape Ophthalmology.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Neurology Journal
Advertisement
